J O Klein

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Management of acute otitis media in an era of increasing antibiotic resistance
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Int J Pediatr Otorhinolaryngol 49:S15-7. 1999
  2. ncbi request reprint Clinical implications of antibiotic resistance for management of acute otitis media
    J O Klein
    Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 17:1084-9; discussion 1099-100. 1998
  3. ncbi request reprint Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply
    Jerome O Klein
    Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Massachusetts, USA
    Pediatrics 117:2269-75. 2006
  4. ncbi request reprint Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions
    Jerome O Klein
    Department of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, MA, USA
    Clin Infect Dis 42:S97-103. 2006
  5. ncbi request reprint Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005
    Jerome O Klein
    Department of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, MA, USA
    Clin Infect Dis 42:S145-50. 2006
  6. doi request reprint Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease
    Jerome O Klein
    Division of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston, Massachusetts 02118, USA
    Clin Infect Dis 47:1197-9. 2008
  7. ncbi request reprint Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization
    Jerome O Klein
    Boston Medical Center, and Department of Medicine, Boston University School of Medicine, MA 02118, USA
    Pediatr Infect Dis J 21:584-8; discussion 613-4. 2002
  8. ncbi request reprint In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 20:102-3; discussion 120-2. 2001
  9. ncbi request reprint The burden of otitis media
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, 774 Albany Street, Boston, MA 02118, USA
    Vaccine 19:S2-8. 2000
  10. ncbi request reprint Management of otitis media: 2000 and beyond
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 19:383-7. 2000

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Management of acute otitis media in an era of increasing antibiotic resistance
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Int J Pediatr Otorhinolaryngol 49:S15-7. 1999
    ....
  2. ncbi request reprint Clinical implications of antibiotic resistance for management of acute otitis media
    J O Klein
    Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 17:1084-9; discussion 1099-100. 1998
    ..If medical management fails to prevent new episodes of AOM in children with severe and recurrent disease, placement of tympanostomy tubes and possible adenoidectomy should be considered...
  3. ncbi request reprint Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply
    Jerome O Klein
    Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Massachusetts, USA
    Pediatrics 117:2269-75. 2006
  4. ncbi request reprint Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions
    Jerome O Klein
    Department of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, MA, USA
    Clin Infect Dis 42:S97-103. 2006
    ..This supplement to Clinical Infectious Diseases includes presentations outlining the problems associated with and proposed solutions for strengthening the supply of routinely administered vaccines in the United States...
  5. ncbi request reprint Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005
    Jerome O Klein
    Department of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, MA, USA
    Clin Infect Dis 42:S145-50. 2006
  6. doi request reprint Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease
    Jerome O Klein
    Division of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston, Massachusetts 02118, USA
    Clin Infect Dis 47:1197-9. 2008
  7. ncbi request reprint Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization
    Jerome O Klein
    Boston Medical Center, and Department of Medicine, Boston University School of Medicine, MA 02118, USA
    Pediatr Infect Dis J 21:584-8; discussion 613-4. 2002
    ..Evaluation of the organism (serotype) and the host (acute and convalescent sera) should be undertaken for each case of invasive pneumococcal disease in this era of universal pneumococcal immunization...
  8. ncbi request reprint In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 20:102-3; discussion 120-2. 2001
    ..The quinolones have particular value as ototopical agents because of the broad spectrum of antibacterial activity of importance in otic diseases and the high concentrations of antibacterial activity at the site of infection...
  9. ncbi request reprint The burden of otitis media
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, 774 Albany Street, Boston, MA 02118, USA
    Vaccine 19:S2-8. 2000
    ..The incidence and severity of OM may diminish with introduction of new bacterial and viral vaccines...
  10. ncbi request reprint Management of otitis media: 2000 and beyond
    J O Klein
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, MA 02118, USA
    Pediatr Infect Dis J 19:383-7. 2000
    ..Guidelines stress limiting usage of antimicrobial agents to diseases that are likely caused by bacterial pathogens. Antiviral drugs are now available against influenza virus and respiratory syncytial virus infections...
  11. ncbi request reprint Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children
    E D Barnett
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, and Boston University School of Public Health, Massachusetts 02118, USA
    Clin Infect Dis 29:191-2. 1999
    ..Pneumococcal conjugate vaccine has the potential to reduce the incidence of disease due to vaccine serotypes, even among children with recurrent otitis media...
  12. ncbi request reprint Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
    T A Lieu
    Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Mass 02215, USA
    JAMA 283:1460-8. 2000
    ..Pneumococcal conjugate vaccine for infants has recently been found effective against meningitis, bacteremia, pneumonia, and otitis media...
  13. ncbi request reprint Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades
    F E Babl
    Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA
    Clin Infect Dis 32:1155-61. 2001
    ..A comparison of these findings with historical pediatric data from our institution showed serogroup stability dating back to 1957...
  14. ncbi request reprint The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children
    Stephen I Pelton
    Department of Pediatrics, Boston University School of Medicine, and Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Boston, Massachusetts 02118, USA
    Pediatrics 110:805-14. 2002
    ....
  15. ncbi request reprint Pneumococcal vaccines for infants and children--past, present, and future
    Jerome O Klein
    Boston University School of Medicine, Department of Pediatrics, Boston Medical Center, Boston, Massachusetts, USA
    Curr Clin Top Infect Dis 22:252-65. 2002
  16. ncbi request reprint Disruptions in the supply of routinely recommended childhood vaccines in the United States
    Jeanne M Santoli
    Pediatr Infect Dis J 23:553-4. 2004
  17. ncbi request reprint What's new in the diagnosis and management of otitis media?
    Jerome O Klein
    Pediatr Ann 31:777-8. 2002
  18. ncbi request reprint Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections
    Jerome O Klein
    Boston University School of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Massachusetts, USA
    Am J Manag Care 8:S345-52. 2002
    ....
  19. ncbi request reprint Recent advances in otitis media. 7. Vaccine
    Lauren O Bakaletz
    Ann Otol Rhinol Laryngol Suppl 188:82-94. 2002
  20. ncbi request reprint Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee
    Jeanne M Santoli
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    JAMA 290:3122-8. 2003
    ..Strategies requiring further study include evaluation of appropriate financial incentives to manufacturers and streamlining the regulatory process without compromising safety or efficacy...